Statistics for Telotristat ethyl, a tryptophan hydroxylase inhibitor, enhances antitumor efficacy of standard chemotherapy in preclinical cholangiocarcinoma models
Total visits
| views | |
|---|---|
| Telotristat ethyl, a tryptophan hydroxylase inhibitor, enhances antitumor efficacy of standard chemotherapy in preclinical cholangiocarcinoma models | 0 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:79176226-441d-42f9-90f3-9b740173f22d | 13 |
| java.util.UUID:de2e0736-131c-46d1-a9a2-3e6a545b00e7 | 11 |
| Awasthi2024Telotristat-CCBY.pdf | 2 |
| java.util.UUID:c8038a38-15f2-4d13-a8db-05a1ee9d2d37 | 1 |